SCHEMBL16161985

SCHEMBL16161985

C[C@](Cc1ccccc1)(OC(N)=O)C(N)=NO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
HIF1A Q16665 1/20 0.41
SLC6A2 P23975 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 1/20 0.38
RECQL P46063 1/20 0.38
MMP8 P22894 3/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
CTBP2 P56545 1/20 0.37
PLA2G10 O15496 1/20 0.37
PLA2G2A P14555 1/20 0.37
PARP10 Q53GL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16161984 1.00 PPARG (0.43) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL476211 0.81 PPARG (0.46) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL2641207 0.80 PPARG (0.44) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL14675862 0.79 PPARG (0.43) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL2365133 0.79 PPARG (0.43) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL3656311 0.77 SMN1; SMN2 (0.48) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL9278784 0.77 HIF1A (0.48) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL27675004 0.77 MMP8 (0.45) PPARGPPARASMN1; SMN2HIF1ASLC6A2
SCHEMBL12993700 0.73 CA12 (0.44) PPARGPPARACYP3A4CYP1A2RECQL
SCHEMBL7619909 0.73 SLC6A2 (0.48) PPARGPPARASMN1; SMN2HIF1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740559-B1 1,3,5-SUBSTITUTED PHENYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2014-10-15 EP disclosed